| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |